Coeliac Disease Trial, Recruiting NCT06793527 Sponsor: Jagiellonian University Condition: Coeliac Disease
Back to Coeliac Disease

Coeliac Disease Trial, Recruiting

NCT06793527
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older and have had weight-loss (bariatric) surgery performed using a keyhole (laparoscopic) technique
  • You are able and willing to sign an agreement to take part in the study

Who may not be able to join:

  • You have a history of allergic reactions to medications
  • You have a history of drug addiction
  • You have long-term (chronic) pain that requires you to regularly take pain-relief medication
  • You have previously been admitted to hospital for a mental health condition
  • Your blood oxygen level measured before surgery was below 95% (confirm with trial site)
  • You have a slower than normal heart rate (fewer than 50 beats per minute)
  • You have low blood pressure
  • You have a condition affecting the electrical signals between the upper and lower chambers of your heart (confirm with trial site)
  • You have a condition affecting the electrical signals within the heart's chambers or its natural pacemaker (confirm with trial site)
  • You have a blood clotting disorder that makes it harder for your blood to clot normally
  • You are pregnant or currently breastfeeding
  • You have a condition that affects your thinking, memory, or understanding
  • You are unable to read the consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tomasz Skladzien, MD PhD, Jagiellonian University

Phone: 124001800

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Jagiellonian University
Registry
ClinicalTrials.gov
Start date
6 February 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Life quality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov